Culha M, Mutlu N, Acar O, Alici B
Department of Urology, Kocaeli University Faculty of Medicine, Turkey.
Int Urol Nephrol. 1999;31(2):257-62. doi: 10.1023/a:1007193212522.
We attempted to find the most adequate treatment option for some selected cases of Peyronie's disease. Between 1993 and 1996, 38 patients with Peyronie's disease and erectile dysfunction were treated with intracavernous medication, supported with oral colchicine and vitamin E. None of the cases had severe angulation of penis and intolerable pain during erection. Quality of sexual life was assessed by CWRU questionnaire. After ten-month follow-up we found improvement in all parameters, in CWRU. The symptoms of 24 cases diminished. The 21 partners examined were also satisfied with the therapy. We conclude that intracavernous medication combined with oral agents is a useful alternative treatment in selected cases of Peyronie's disease.
我们试图为一些选定的佩罗尼氏病病例找到最适当的治疗方案。1993年至1996年间，38例患有佩罗尼氏病和勃起功能障碍的患者接受了海绵体内药物治疗，并辅以口服秋水仙碱和维生素E。所有病例在勃起时均无阴茎严重弯曲和无法忍受的疼痛。性生活质量通过凯斯西储大学（CWRU）问卷进行评估。经过十个月的随访，我们发现凯斯西储大学问卷中的所有参数均有改善。24例患者的症状减轻。接受检查的21名伴侣也对该治疗感到满意。我们得出结论，海绵体内药物联合口服药物是佩罗尼氏病选定病例的一种有用的替代治疗方法。
